P16 deletion in sarcomatoid tumors of the lung and pleura

Naobumi Tochigi, Richard Attanoos, Lucian R. Chirieac, Timothy Craig Allen, Philip T. Cagle, Sanja Dacic

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Context.- The diagnosis of sarcomatoid neoplasms of the lung and pleura can be challenging. Homozygous deletion of 9p21, the locus harboring the p16 gene, has been reported as the most common genetic alteration in malignant mesotheliomas that is of potential diagnostic and prognostic significance. Objectives.- To evaluate the frequency of 9p21 deletion by fluorescence in situ hybridization in the primary sarcomatoid neoplasms of the lung and pleura and to determine its potential diagnostic utility. Design.- Ninety-two sarcomatoid neoplasms of the lung and pleura (32 sarcomatoid mesotheliomas, 15 sarcomatoid carcinomas, 32 solitary fibrous tumors, and 13 highgrade sarcomas) were examined for 9p21 deletion by fluorescence in situ hybridization. Results.- Deletion of 9p21 was most frequently seen in malignant mesotheliomas (81%), followed by sarcomatoid carcinomas (53%), sarcomas (25%), and solitary fibrous tumors (12.5%). Malignant mesotheliomas showed mostly homozygous deletion, whereas sarcomatoid carcinomas showed either homozygous or hemizygous deletion. None of the sarcomas showed homozygous deletion. There was a trend toward more frequent occurrence of 9p21 deletion in recurrent solitary fibrous tumors, but this did not reach statistical difference. Conclusions.- Deletion of 9p21 is common in sarcomatoid tumors of the lung and pleura. Despite statistically significant differences in the frequency of 9p21 deletion, and because of the large overlap among the study groups, this genetic abnormality cannot be used as a reliable diagnostic tool in the assessment of sarcomatoid lesions of the lung and pleura. A potential use of p16 deletion in predicting the biology of solitary fibrous tumors should be further explored.

Original languageEnglish (US)
Pages (from-to)632-636
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume137
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Pleura
Solitary Fibrous Tumors
Lung
Sarcoma
Lung Neoplasms
Neoplasms
Carcinoma
Fluorescence In Situ Hybridization
p16 Genes
Mesothelioma
Malignant Mesothelioma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Tochigi, N., Attanoos, R., Chirieac, L. R., Allen, T. C., Cagle, P. T., & Dacic, S. (2013). P16 deletion in sarcomatoid tumors of the lung and pleura. Archives of Pathology and Laboratory Medicine, 137(5), 632-636. https://doi.org/10.5858/arpa.2012-0108-OA

P16 deletion in sarcomatoid tumors of the lung and pleura. / Tochigi, Naobumi; Attanoos, Richard; Chirieac, Lucian R.; Allen, Timothy Craig; Cagle, Philip T.; Dacic, Sanja.

In: Archives of Pathology and Laboratory Medicine, Vol. 137, No. 5, 05.2013, p. 632-636.

Research output: Contribution to journalArticle

Tochigi, N, Attanoos, R, Chirieac, LR, Allen, TC, Cagle, PT & Dacic, S 2013, 'P16 deletion in sarcomatoid tumors of the lung and pleura', Archives of Pathology and Laboratory Medicine, vol. 137, no. 5, pp. 632-636. https://doi.org/10.5858/arpa.2012-0108-OA
Tochigi, Naobumi ; Attanoos, Richard ; Chirieac, Lucian R. ; Allen, Timothy Craig ; Cagle, Philip T. ; Dacic, Sanja. / P16 deletion in sarcomatoid tumors of the lung and pleura. In: Archives of Pathology and Laboratory Medicine. 2013 ; Vol. 137, No. 5. pp. 632-636.
@article{31ed1aaf0e1f407f97a68dcbaafe2370,
title = "P16 deletion in sarcomatoid tumors of the lung and pleura",
abstract = "Context.- The diagnosis of sarcomatoid neoplasms of the lung and pleura can be challenging. Homozygous deletion of 9p21, the locus harboring the p16 gene, has been reported as the most common genetic alteration in malignant mesotheliomas that is of potential diagnostic and prognostic significance. Objectives.- To evaluate the frequency of 9p21 deletion by fluorescence in situ hybridization in the primary sarcomatoid neoplasms of the lung and pleura and to determine its potential diagnostic utility. Design.- Ninety-two sarcomatoid neoplasms of the lung and pleura (32 sarcomatoid mesotheliomas, 15 sarcomatoid carcinomas, 32 solitary fibrous tumors, and 13 highgrade sarcomas) were examined for 9p21 deletion by fluorescence in situ hybridization. Results.- Deletion of 9p21 was most frequently seen in malignant mesotheliomas (81{\%}), followed by sarcomatoid carcinomas (53{\%}), sarcomas (25{\%}), and solitary fibrous tumors (12.5{\%}). Malignant mesotheliomas showed mostly homozygous deletion, whereas sarcomatoid carcinomas showed either homozygous or hemizygous deletion. None of the sarcomas showed homozygous deletion. There was a trend toward more frequent occurrence of 9p21 deletion in recurrent solitary fibrous tumors, but this did not reach statistical difference. Conclusions.- Deletion of 9p21 is common in sarcomatoid tumors of the lung and pleura. Despite statistically significant differences in the frequency of 9p21 deletion, and because of the large overlap among the study groups, this genetic abnormality cannot be used as a reliable diagnostic tool in the assessment of sarcomatoid lesions of the lung and pleura. A potential use of p16 deletion in predicting the biology of solitary fibrous tumors should be further explored.",
author = "Naobumi Tochigi and Richard Attanoos and Chirieac, {Lucian R.} and Allen, {Timothy Craig} and Cagle, {Philip T.} and Sanja Dacic",
year = "2013",
month = "5",
doi = "10.5858/arpa.2012-0108-OA",
language = "English (US)",
volume = "137",
pages = "632--636",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "5",

}

TY - JOUR

T1 - P16 deletion in sarcomatoid tumors of the lung and pleura

AU - Tochigi, Naobumi

AU - Attanoos, Richard

AU - Chirieac, Lucian R.

AU - Allen, Timothy Craig

AU - Cagle, Philip T.

AU - Dacic, Sanja

PY - 2013/5

Y1 - 2013/5

N2 - Context.- The diagnosis of sarcomatoid neoplasms of the lung and pleura can be challenging. Homozygous deletion of 9p21, the locus harboring the p16 gene, has been reported as the most common genetic alteration in malignant mesotheliomas that is of potential diagnostic and prognostic significance. Objectives.- To evaluate the frequency of 9p21 deletion by fluorescence in situ hybridization in the primary sarcomatoid neoplasms of the lung and pleura and to determine its potential diagnostic utility. Design.- Ninety-two sarcomatoid neoplasms of the lung and pleura (32 sarcomatoid mesotheliomas, 15 sarcomatoid carcinomas, 32 solitary fibrous tumors, and 13 highgrade sarcomas) were examined for 9p21 deletion by fluorescence in situ hybridization. Results.- Deletion of 9p21 was most frequently seen in malignant mesotheliomas (81%), followed by sarcomatoid carcinomas (53%), sarcomas (25%), and solitary fibrous tumors (12.5%). Malignant mesotheliomas showed mostly homozygous deletion, whereas sarcomatoid carcinomas showed either homozygous or hemizygous deletion. None of the sarcomas showed homozygous deletion. There was a trend toward more frequent occurrence of 9p21 deletion in recurrent solitary fibrous tumors, but this did not reach statistical difference. Conclusions.- Deletion of 9p21 is common in sarcomatoid tumors of the lung and pleura. Despite statistically significant differences in the frequency of 9p21 deletion, and because of the large overlap among the study groups, this genetic abnormality cannot be used as a reliable diagnostic tool in the assessment of sarcomatoid lesions of the lung and pleura. A potential use of p16 deletion in predicting the biology of solitary fibrous tumors should be further explored.

AB - Context.- The diagnosis of sarcomatoid neoplasms of the lung and pleura can be challenging. Homozygous deletion of 9p21, the locus harboring the p16 gene, has been reported as the most common genetic alteration in malignant mesotheliomas that is of potential diagnostic and prognostic significance. Objectives.- To evaluate the frequency of 9p21 deletion by fluorescence in situ hybridization in the primary sarcomatoid neoplasms of the lung and pleura and to determine its potential diagnostic utility. Design.- Ninety-two sarcomatoid neoplasms of the lung and pleura (32 sarcomatoid mesotheliomas, 15 sarcomatoid carcinomas, 32 solitary fibrous tumors, and 13 highgrade sarcomas) were examined for 9p21 deletion by fluorescence in situ hybridization. Results.- Deletion of 9p21 was most frequently seen in malignant mesotheliomas (81%), followed by sarcomatoid carcinomas (53%), sarcomas (25%), and solitary fibrous tumors (12.5%). Malignant mesotheliomas showed mostly homozygous deletion, whereas sarcomatoid carcinomas showed either homozygous or hemizygous deletion. None of the sarcomas showed homozygous deletion. There was a trend toward more frequent occurrence of 9p21 deletion in recurrent solitary fibrous tumors, but this did not reach statistical difference. Conclusions.- Deletion of 9p21 is common in sarcomatoid tumors of the lung and pleura. Despite statistically significant differences in the frequency of 9p21 deletion, and because of the large overlap among the study groups, this genetic abnormality cannot be used as a reliable diagnostic tool in the assessment of sarcomatoid lesions of the lung and pleura. A potential use of p16 deletion in predicting the biology of solitary fibrous tumors should be further explored.

UR - http://www.scopus.com/inward/record.url?scp=84877969898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877969898&partnerID=8YFLogxK

U2 - 10.5858/arpa.2012-0108-OA

DO - 10.5858/arpa.2012-0108-OA

M3 - Article

VL - 137

SP - 632

EP - 636

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 5

ER -